Overview
Superior mesenteric artery (SMA) occlusion is a life-threatening condition characterized by acute mesenteric ischemia, often due to emboli or thrombosis, leading to bowel ischemia and potential necrosis if not promptly addressed 2.Diagnosis
Elevated plasma digoxin synthesis and altered isoprenoid pathway markers (increased dolichol, decreased ubiquinone) may indicate predisposition 1.
Imaging studies such as CT angiography or mesenteric Doppler ultrasound are crucial for visualizing occlusion and assessing bowel perfusion 2.
Laboratory findings may include decreased RBC membrane Na(+)-K+ ATPase activity and serum magnesium levels 1.Management
First-line treatment: Selective delivery of low-dose streptokinase via catheter techniques for clot lysis in celiac and SMA occlusions 2.
Adjunctive measures: Restoration of mesenteric blood flow is critical; surgical intervention may be necessary if medical management fails 2.Special Populations
No specific data provided in the abstracts regarding pregnancy, pediatrics, elderly, or comorbidities related to SMA occlusion management 12.Key Recommendations
Utilize selective low-dose streptokinase delivery via catheter techniques for the lysis of occlusive clots in SMA and celiac artery occlusions to restore mesenteric blood flow (Evidence: Moderate) 2.
Monitor and address biochemical markers indicative of vascular compromise, such as altered digoxin levels and ubiquinone deficiency, in patients at risk for SMA occlusion (Evidence: Weak) 1.
Consider surgical intervention if endovascular treatments fail to restore adequate mesenteric perfusion (Evidence: Expert opinion) 2.References
1 Kurup RK, Kurup PA. Hypothalamic digoxin, hemispheric chemical dominance, and mesenteric artery occlusion. The International journal of neuroscience 2003. link
2 Pillari G, Doscher W, Fierstein J, Ross W, Loh G, Berkowitz BJ. Low-dose streptokinase in the treatment of celiac and superior mesenteric artery occlusion. Archives of surgery (Chicago, Ill. : 1960) 1983. link